{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:39:19Z","timestamp":1781951959394,"version":"3.54.5"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3,27]]},"DOI":"10.1097\/tp.0b013e3181c7dcc0","type":"journal-article","created":{"date-parts":[[2010,3,15]],"date-time":"2010-03-15T18:49:21Z","timestamp":1268678961000},"page":"733-738","source":"Crossref","is-referenced-by-count":56,"title":["First Report on a Series of HIV Patients Undergoing Rapamycin Monotherapy After Liver Transplantation"],"prefix":"10.1097","volume":"89","author":[{"given":"Fabrizio","family":"Di Benedetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Di Sandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"De Ruvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Montalti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ballarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Piero","family":"Guerrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Spaggiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Guaraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gerunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210129","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.immunol.14.1.483","article-title":"Immunopharmacology of rapamycin.","volume":"14","author":"Abraham","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"R2-17-20210129","first-page":"964","article-title":"Mechanism of action of rapamycin (Sirolimus, Rapamune).","volume":"28","author":"Molnar-Kimber","year":"1996","journal-title":"Transplant Proc"},{"key":"R3-17-20210129","doi-asserted-by":"crossref","first-page":"12574","DOI":"10.1073\/pnas.91.26.12574","article-title":"RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12\/rapamycin complex.","volume":"91","author":"Chiu","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R4-17-20210129","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.277.5322.99","article-title":"Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin.","volume":"277","author":"Brunn","year":"1997","journal-title":"Science"},{"key":"R5-17-20210129","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0955-0674(97)80078-6","article-title":"TOR signalling and control of cell growth.","volume":"9","author":"Thomas","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"R6-17-20210129","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0092-8674(00)80110-5","article-title":"Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.","volume":"86","author":"Liu","year":"1996","journal-title":"Cell"},{"key":"R7-17-20210129","doi-asserted-by":"crossref","first-page":"15590","DOI":"10.1073\/pnas.242134499","article-title":"Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.","volume":"99","author":"Lin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R8-17-20210129","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1086\/315303","article-title":"Interleukin-2 up-regulates expression of the human immunodeficiency virus fusion coreceptor CCR5 by CD4+ lymphocytes in vivo.","volume":"181","author":"Weissman","year":"2000","journal-title":"J Infect Dis"},{"key":"R9-17-20210129","doi-asserted-by":"crossref","first-page":"10411","DOI":"10.1073\/pnas.1834278100","article-title":"Rapamycin causes down-regulation of CCR5 and accumulation of anti-HIV beta-chemokines: An approach to suppress R5 strains of HIV-1.","volume":"100","author":"Heredia","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"R10-17-20210129","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"R11-17-20210129","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival.","volume":"33","author":"Yao","year":"2001","journal-title":"Hepatology"},{"key":"R12-17-20210129","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1053\/jlts.2003.50113","article-title":"Independent risk factors and natural history of renal dysfunction in liver transplant recipients","volume":"9","author":"Pawarode","year":"2003","journal-title":"Liver Transpl"},{"key":"R13-17-20210129","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1097\/01.tp.0000262607.95372.e0","article-title":"De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: Long-term outcomes and side effects.","volume":"83","author":"Toso","year":"2007","journal-title":"Transplantation"},{"key":"R14-17-20210129","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/lt.20237","article-title":"Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma.","volume":"10","author":"Kneteman","year":"2004","journal-title":"Liver Transpl"},{"key":"R15-17-20210129","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00432-007-0329-3","article-title":"Kaposi's sarcoma after liver transplantation.","volume":"134","author":"Di Benedetto","year":"2008","journal-title":"J Cancer Res Clin Oncol"},{"key":"R16-17-20210129","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jhep.2004.11.029","article-title":"Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.","volume":"42","author":"Duclos-Vall\u00e9e","year":"2005","journal-title":"J Hepatol"},{"key":"R17-17-20210129","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jhep.2005.08.005","article-title":"Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantation for HCV cirrhosis.","volume":"43","author":"Samonakis","year":"2005","journal-title":"J Hepatol"},{"key":"R18-17-20210129","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1073\/pnas.012519099","article-title":"HIV-1 escape from a small molecule, CCR5-specific entry inhibitor does not involve CXCR4 use.","volume":"99","author":"Trkola","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"R19-17-20210129","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1126\/science.1099288","article-title":"Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.","volume":"306","author":"Lederman","year":"2004","journal-title":"Science"},{"key":"R20-17-20210129","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20031266","article-title":"Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection.","volume":"198","author":"Veazey","year":"2003","journal-title":"J Exp Med"},{"key":"R21-17-20210129","first-page":"97","article-title":"HIV-1 coreceptors and their inhibitors.","volume":"303","author":"Ray","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"R22-17-20210129","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1097\/QAD.0b013e3282f02a4f","article-title":"Rapamycin reduces CCR5 mRNA levels in macaques: Potential applications in HIV-1 prevention and treatment.","volume":"21","author":"Gilliam","year":"2007","journal-title":"AIDS"},{"key":"R23-17-20210129","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1128\/AAC.46.11.3447-3455.2002","article-title":"The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication.","volume":"46","author":"Roy","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-17-20210129","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1128\/AAC.01602-06","article-title":"Rapamycin reduces CCR5 density levels on CD4 T cells, and this effect results in potentiation of enfuvirtide (T-20) against R5 strains of human immunodeficiency virus type 1 in vitro.","volume":"51","author":"Heredia","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"R25-17-20210129","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/QAD.0b013e3282f37478","article-title":"Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation.","volume":"22","author":"Moreno","year":"2008","journal-title":"AIDS"},{"key":"R26-17-20210129","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1073\/pnas.0630584100","article-title":"Induction of G1 cycle arrest in T lymphocytes results in increased extracellular levels of beta-chemokines: A strategy to inhibit R5 HIV-1.","volume":"100","author":"Heredia","year":"2003","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0b013e3181c7dcc0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:19:08Z","timestamp":1620976748000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201003270-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,27]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181c7dcc0","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3,27]]}}}